Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Tuberculosis

  Free Subscription


09.02.2026

1 Am J Epidemiol
1 Antimicrob Agents Chemother
3 Clin Infect Dis
5 Int J Tuberc Lung Dis
1 J Infect Dis
1 PLoS Med
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Epidemiol

  1. LAHOOD A, Robins J, Stagg HR, Sauer S, et al
    Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherence.
    Am J Epidemiol. 2026 Feb 2:kwag024. doi: 10.1093.
    PubMed         Abstract available


    Antimicrob Agents Chemother

  2. LAMONT EA, Kordus SL, Howe MD, Jia Z, et al
    Essential role of MHC II in the antitubercular efficacy of pyrazinamide.
    Antimicrob Agents Chemother. 2026;70:e0126425.
    PubMed         Abstract available


    Clin Infect Dis

  3. SOLOVYEVA AV, Volchenkov GV, Ponomarenko OI, Kuznezova TA, et al
    Implementing a Program of Comprehensive Tuberculosis Preventive Treatment: Safety, Effectiveness, and Acceptability of Moxifloxacin or Bedaquiline Use for Contacts Exposed to Drug-Resistant Strains.
    Clin Infect Dis. 2026 Feb 3:ciaf701. doi: 10.1093.
    PubMed         Abstract available

  4. MANZOOR F, Rhee C, Baker MA, Klompas M, et al
    Mycobacterium tuberculosis Transmission in Healthcare Settings: A Systematic Review of Frequency, Risk Factors, and Exposure Conditions.
    Clin Infect Dis. 2026 Jan 30:ciag053. doi: 10.1093.
    PubMed         Abstract available

  5. SWARTWOOD NA, Cohen T, Marks SM, Hill AN, et al
    Effects of the COVID-19 pandemic on TB outcomes in the United States: a Bayesian analysis.
    Clin Infect Dis. 2025 Feb 27:ciaf092. doi: 10.1093.
    PubMed         Abstract available


    Int J Tuberc Lung Dis

  6. SANA H, Saunders MJ, McQuaid CF, Dauphinais MR, et al
    Nutritional interventions for TB: a critical component of integrated TB care amid funding challenges.
    Int J Tuberc Lung Dis. 2026;30:45-47.
    PubMed         Abstract available

  7. WARDANI NHK, Tjia KD
    Spatiotemporal and risk factor analysis of drug-sensitive and drug-resistant TB in West Java, 2020-2022.
    Int J Tuberc Lung Dis. 2026;30:56-62.
    PubMed         Abstract available

  8. KIWANUKA N, Quach HT, Kakaire R, Zalwango S, et al
    Incidence of Mycobacterium tuberculosis infection in an African city with endemic TB.
    Int J Tuberc Lung Dis. 2026;30:70-76.
    PubMed         Abstract available

  9. OU WF, Chu CH, Sheu CC, Chang CL, et al
    Lower FEV(1) and gram-negative bacilli isolation as independent risk factors for exacerbations in post-TB bronchiectasis.
    Int J Tuberc Lung Dis. 2026;30:63-69.
    PubMed         Abstract available

  10. KHAW CR, Malhotra AM, Tehranchi S, Rahman A, et al
    Extra-pulmonary TB: a comparison between migrants and populations born in a low-incidence country.
    Int J Tuberc Lung Dis. 2026;30:77-83.
    PubMed         Abstract available


    J Infect Dis

  11. RYCKMAN TS, Shrestha S, Fojo AT, Kasaie P, et al
    Modeling the impact of case finding for tuberculosis: The role of infection dynamics.
    J Infect Dis. 2026 Jan 30:jiag050. doi: 10.1093.
    PubMed         Abstract available


    PLoS Med

  12. SCHWALB A, Dodd PJ, Rickman HM, Ugarte-Gil CA, et al
    Estimating the global burden of viable Mycobacterium tuberculosis infection: A mathematical modelling study.
    PLoS Med. 2026;23:e1004920.
    PubMed         Abstract available


    PLoS One

  13. GEBRIE E, Baynes HW, Mengistie BA, Kassie T, et al
    Sex hormone profiles and associated factors among adult tuberculosis patients at Gondar town, northwest Ethiopia: A comparative cross-sectional study.
    PLoS One. 2026;21:e0340631.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum